標題: Titlebook: Cell Therapy; Current Status and F Dwaine F. Emerich,Gorka Orive Book 2017 Springer International Publishing AG 2017 cell transplant imagin [打印本頁] 作者: 一再 時間: 2025-3-21 18:06
書目名稱Cell Therapy影響因子(影響力)
書目名稱Cell Therapy影響因子(影響力)學科排名
書目名稱Cell Therapy網(wǎng)絡公開度
書目名稱Cell Therapy網(wǎng)絡公開度學科排名
書目名稱Cell Therapy被引頻次
書目名稱Cell Therapy被引頻次學科排名
書目名稱Cell Therapy年度引用
書目名稱Cell Therapy年度引用學科排名
書目名稱Cell Therapy讀者反饋
書目名稱Cell Therapy讀者反饋學科排名
作者: Frequency-Range 時間: 2025-3-21 21:10 作者: 捏造 時間: 2025-3-22 03:53 作者: 可憎 時間: 2025-3-22 07:58 作者: rods366 時間: 2025-3-22 11:14
Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions,fic antigen, efficient introduction of the antigen into DCs for processing and presentation to the activated T cells, preparation of the correct amount of DCs, and route of administration of DCs to patients. With further research and refinement, DC vaccination may prove both efficacious and widely a作者: 錯事 時間: 2025-3-22 14:50 作者: 錯事 時間: 2025-3-22 17:46 作者: 裁決 時間: 2025-3-22 21:36
Cell Therapy for Ophthalmic Diseases,enetic engineering, recombinant protein production, stem cell technology, and cell therapy manufacturing have been developed which are overcoming many of the challenges encountered in early attempts to develop effective and safe ophthalmic cell therapy products. As a result of these technical advanc作者: Obliterate 時間: 2025-3-23 03:31 作者: Processes 時間: 2025-3-23 06:09 作者: Insubordinate 時間: 2025-3-23 10:28 作者: cultivated 時間: 2025-3-23 16:02 作者: 碌碌之人 時間: 2025-3-23 21:29
J. F. M. Burg,R. P. van de Rietects and increases cell functionality and viability. This chapter will focus on the utility of both naturally occurring and synthetic biomaterial systems to bypass some of the current limitations of cell-based approaches for revascularization therapies. Distinctively, this chapter will cover both th作者: 北極人 時間: 2025-3-24 00:12
Vania M. P. Vidal,Marianne Winslettly, the use of reprogrammed cells as a model for human pathologies, mainly rare diseases, the different aspects that should be bear in mind for optimal model development, the use of gene editing for creating novel and improved disease models, and the therapeutic applications of iPSC-based models hav作者: 有助于 時間: 2025-3-24 05:08 作者: muffler 時間: 2025-3-24 08:53 作者: languor 時間: 2025-3-24 13:02 作者: 美食家 時間: 2025-3-24 17:12
https://doi.org/10.1007/BFb0018076ng glucoresponsive stem cell-derived β-cells, there is a renewed sense of promise in the field driven by the quality and quantity of available cell sources. Several strategies are in development that address the failure modes associated with encapsulation including hypoxia within the encapsulated bi作者: 錫箔紙 時間: 2025-3-24 21:12
Fran?oise Mullie,Jacques Reisseeases, stroke and traumatic brain injury (TBI), share major pathological similarities, with acute and chronic pathways leading to neurodegeneration. In particular, the neuroinflammatory aspect of stroke and TBI pathology has been shown to contribute significantly to worsening outcomes. Fortunately, 作者: 削減 時間: 2025-3-25 01:13
Upward drawings to fit surfaces,arkinson’s is a progressive neurodegenerative disorder predominantly affecting midbrain, dopaminergic neurons along the nigrostriatal pathway. Abrogation of dopamine supply induces motor dysfunction and may play a role in other areas such as cognition and behavioral dysfunction. Current targeted tre作者: Detonate 時間: 2025-3-25 04:32
Lecture Notes in Computer Scienceactory to medical treatment, and, therefore, it is important to search for alternative treatments. One of these alternative approaches could be cell therapy. In this chapter, we provide an overview of the results obtained by the direct grafting of cells in various animal models of drug-resistant epi作者: 通知 時間: 2025-3-25 11:30 作者: 做方舟 時間: 2025-3-25 13:04 作者: Progesterone 時間: 2025-3-25 19:49
J. F. M. Burg,R. P. van de Rietnding cell-based therapies has resulted in more than 14,560 clinical trials recorded by the NIH over the last decade; however, these trials have not resulted in consistent clinical benefit. These disappointing results could stem from both biological and engineering challenges. While supporting the s作者: MARS 時間: 2025-3-25 21:21 作者: 獸群 時間: 2025-3-26 01:34 作者: ETHER 時間: 2025-3-26 04:18 作者: 征兵 時間: 2025-3-26 11:47
https://doi.org/10.1007/BFb0020710slational sciences. The motivation for this increased effort is the lack of treatment options for patients with debilitating and permanent loss of vision. The intricate anatomy and complex physiology of the eye pose unique challenges for potential ophthalmic therapeutics. These challenges are exacer作者: 溺愛 時間: 2025-3-26 15:51
Scheduling pipelined parallelism,er futuristic technologies, exotic therapies need to be more medically effective than current treatments, sufficiently robust to be scaled reproducibly, and economically viable as a commercial product. This chapter is a primer on what an academic cell biologist/inventor may expect when seeking fundi作者: 深淵 時間: 2025-3-26 20:22
https://doi.org/10.1007/BFb0020710d cons in the use of stem cells in clinical trials and the set of problems linked to the fine-tuning of protocols finalized to the generation of large numbers of transplantable cells. We will describe the experimental studies focused on the analysis of survival and functional efficacy of the grafted作者: 我還要背著他 時間: 2025-3-26 22:31 作者: fledged 時間: 2025-3-27 02:44 作者: Indict 時間: 2025-3-27 06:36 作者: 龍蝦 時間: 2025-3-27 12:14
Dwaine F. Emerich,Gorka OriveProvide a comprehensive, state-of-the art review of the field.Designed to touch on the major areas where the field will make its greatest and most immediate clinical impacts.Written by experts and opi作者: nonsensical 時間: 2025-3-27 16:43 作者: VEIL 時間: 2025-3-27 19:55 作者: Defraud 時間: 2025-3-28 00:03
Lecture Notes in Computer Scienceems and provide an in-depth view of several fields that have been significantly impacted by organoid technology. Finally, we summarize emerging applications of organoids in modeling health and disease, treating patients, and discovering novel pharmaceuticals.作者: ironic 時間: 2025-3-28 04:14
Scheduling pipelined parallelism,ding droplet-, extrusion-, and laser-based bioprinting. There have been successes in bioprinting several tissue types such as the vasculature, cartilage, bone, liver, and cardiac. However, there are several limitations and challenges, which must be overcome prior to a wide-scale clinical application.作者: Camouflage 時間: 2025-3-28 07:27 作者: GEAR 時間: 2025-3-28 12:18 作者: 接觸 時間: 2025-3-28 16:15
3D Printing for Cell Therapy Applications,ding droplet-, extrusion-, and laser-based bioprinting. There have been successes in bioprinting several tissue types such as the vasculature, cartilage, bone, liver, and cardiac. However, there are several limitations and challenges, which must be overcome prior to a wide-scale clinical application.作者: Annotate 時間: 2025-3-28 18:56
2197-7852 d most immediate clinical impacts.Written by experts and opiThis volume provides a comprehensive, state-of-the art review of the field of cell therapy.? The volume begins with an overview of the breadth of the field and then turns to overviews of imaging technologies that can aid in both safety and 作者: 漂浮 時間: 2025-3-29 01:08 作者: 流利圓滑 時間: 2025-3-29 05:32 作者: 推延 時間: 2025-3-29 07:42
Cell Therapy: Approaching a Partnership with Pharma,y, and economically viable as a commercial product. This chapter is a primer on what an academic cell biologist/inventor may expect when seeking funding from a typical pharmaceutical company to develop a cell therapy.作者: PHIL 時間: 2025-3-29 12:16 作者: insert 時間: 2025-3-29 15:58 作者: vocation 時間: 2025-3-29 20:22
https://doi.org/10.1007/BFb0018076inst elements of the immune system. This review chapter highlights some of the key innovations in each of these areas of beta cell encapsulation and provides context as stem cell strategies advance to the clinic.作者: 星星 時間: 2025-3-30 02:35
,Considerations for Successful Encapsulated β-Cell Therapy,inst elements of the immune system. This review chapter highlights some of the key innovations in each of these areas of beta cell encapsulation and provides context as stem cell strategies advance to the clinic.作者: intolerance 時間: 2025-3-30 07:21
Book 2017field and then turns to overviews of imaging technologies that can aid in both safety and efficacy evaluations. The book then turns to numerous contributions detailing the rapidly growing field of stem cell therapies. These sections cover our understanding of the natural roles of stem cells in biolo作者: Additive 時間: 2025-3-30 11:19
Cell Therapy for Epilepsy,lepsy and discuss the potential of this approach and the issues that remain to be addressed before attempting translation in humans. In addition, we discuss a new cell therapy approach based on the encapsulated cell biodelivery (ECB) system and introduce preliminary data from our laboratory.作者: Yag-Capsulotomy 時間: 2025-3-30 15:18 作者: 乞討 時間: 2025-3-30 17:50 作者: 一小塊 時間: 2025-3-30 23:34
Stem Cell Therapy for Neurovascular and Traumatic Brain Diseases,eases, stroke and traumatic brain injury (TBI), share major pathological similarities, with acute and chronic pathways leading to neurodegeneration. In particular, the neuroinflammatory aspect of stroke and TBI pathology has been shown to contribute significantly to worsening outcomes. Fortunately, 作者: 材料等 時間: 2025-3-31 02:39
,Cell Replacement Strategies for Parkinson’s Disease,arkinson’s is a progressive neurodegenerative disorder predominantly affecting midbrain, dopaminergic neurons along the nigrostriatal pathway. Abrogation of dopamine supply induces motor dysfunction and may play a role in other areas such as cognition and behavioral dysfunction. Current targeted tre作者: 熟練 時間: 2025-3-31 08:31
Cell Therapy for Epilepsy,actory to medical treatment, and, therefore, it is important to search for alternative treatments. One of these alternative approaches could be cell therapy. In this chapter, we provide an overview of the results obtained by the direct grafting of cells in various animal models of drug-resistant epi作者: 玉米棒子 時間: 2025-3-31 11:20
